izpis_h1_title_alt

Antiviral activities of halogenated emodin derivatives against human coronavirus NL63
ID Horvat, Monika (Avtor), ID Avbelj, Martina (Avtor), ID Durán-Alonso, María Beatriz (Avtor), ID Banjanac, Mihailo (Avtor), ID Petković, Hrvoje (Avtor), ID Iskra, Jernej (Avtor)

.pdfPDF - Predstavitvena datoteka, prenos (1,51 MB)
MD5: C0A8F6BC4C5E6584158AB880166C1B05
URLURL - Izvorni URL, za dostop obiščite https://www.mdpi.com/1420-3049/26/22/6825 Povezava se odpre v novem oknu

Izvleček
The current COVID-19 outbreak has highlighted the need for the development of new vaccines and drugs to combat Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2). Recently, various drugs have been proposed as potentially effective against COVID-19, such as remdesivir, infliximab and imatinib. Natural plants have been used as an alternative source of drugs for thousands of years, and some of them are effective for the treatment of various viral diseases. Emodin (1,3,8-trihydroxy-6-methylanthracene-9,10-dione) is a biologically active anthraquinone with antiviral activity that is found in various plants. We studied the selectivity of electrophilic aromatic substitution reactions on an emodin core (halogenation, nitration and sulfonation), which resulted in a library of emodin derivatives. The main aim of this work was to carry out an initial evaluation of the potential to improve the activity of emodin against human coronavirus NL63 (HCoV-NL63) and also to generate a set of initial SAR guidelines. We have prepared emodin derivatives which displayed significant anti-HCoV-NL63 activity. We observed that halogenation of emodin can improve its antiviral activity. The most active compound in this study was the iodinated emodin analogue E_3I, whose anti-HCoV-NL63 activity was comparable to that of remdesivir. Evaluation of the emodin analogues also revealed some unwanted toxicity to Vero cells. Since new synthetic routes are now available that allow modification of the emodin structure, it is reasonable to expect that analogues with significantly improved anti-HCoV-NL63 activity and lowered toxicity may thus be generated.

Jezik:Angleški jezik
Ključne besede:emodin, halogenated emodin, human coronavirus NL63, antiviral activities
Vrsta gradiva:Članek v reviji
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:FKKT - Fakulteta za kemijo in kemijsko tehnologijo
BF - Biotehniška fakulteta
Status publikacije:Objavljeno
Različica publikacije:Objavljena publikacija
Leto izida:2021
Št. strani:16 str.
Številčenje:Vol. 26, iss. 22, art. 6825
PID:20.500.12556/RUL-136415 Povezava se odpre v novem oknu
UDK:547.672
ISSN pri članku:1420-3049
DOI:10.3390/molecules26226825 Povezava se odpre v novem oknu
COBISS.SI-ID:86120963 Povezava se odpre v novem oknu
Datum objave v RUL:03.05.2022
Število ogledov:788
Število prenosov:127
Metapodatki:XML DC-XML DC-RDF
:
Kopiraj citat
Objavi na:Bookmark and Share

Gradivo je del revije

Naslov:Molecules
Skrajšan naslov:Molecules
Založnik:MDPI
ISSN:1420-3049
COBISS.SI-ID:18462981 Povezava se odpre v novem oknu

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.
Začetek licenciranja:11.11.2021

Sekundarni jezik

Jezik:Slovenski jezik
Ključne besede:emodin, halogeniran emodin, človeški koronavirus NL63, protivirusna aktivnost

Projekti

Financer:ARRS - Agencija za raziskovalno dejavnost Republike Slovenije
Številka projekta:P1-0134
Naslov:Kemija za trajnostni razvoj

Financer:ARRS - Agencija za raziskovalno dejavnost Republike Slovenije
Številka projekta:P4-0116
Naslov:Mikrobiologija in biotehnologija živil in okolja

Financer:EC - European Commission
Program financ.:European Regional Development Fund, Urban Innovative Actions
Akronim:APPLAUSE

Podobna dela

Podobna dela v RUL:
Podobna dela v drugih slovenskih zbirkah:

Nazaj